Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides

Gregor Kosec; Stefan Fujs; Hrvoje Petkovic; Oda Cornelia Maria Sibon; Balaji Srinivasan

Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides

Gregor Kosec (Uitvinder), Stefan Fujs (Uitvinder), Hrvoje Petkovic (Uitvinder), Oda Cornelia Maria Sibon (Uitvinder), Balaji Srinivasan (Uitvinder)

Biology-Related, Artificial, and Interventional Neuroscience (BRAIN)

Onderzoeksoutput: Patent

Samenvatting

The invention relates to the use of phosphopantetheine compounds alone and in combination with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Preferred medical uses relate to the treatment or prevention of dyslipidemia.

Originele taal-2	English
Octrooinummer	WO2016102680
Prioriteitsdatum	23/12/2014
Status	Published - 30-jun.-2016

Toegang tot document

https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2016102680A1&KC=A1&FT=D&ND=3&date=20160630&DB=&locale=en_EP

Handle.net

Permanente koppeling

Citeer dit

Kosec, G., Fujs, S., Petkovic, H., Sibon, O. C. M., & Srinivasan, B. (2016). Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides. (Octrooi Nr. WO2016102680). https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2016102680A1&KC=A1&FT=D&ND=3&date=20160630&DB=&locale=en_EP

@misc{ed8cc8634eb543f18b80d572ed856177,

title = "Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides",

abstract = "The invention relates to the use of phosphopantetheine compounds alone and in combination with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Preferred medical uses relate to the treatment or prevention of dyslipidemia.",

author = "Gregor Kosec and Stefan Fujs and Hrvoje Petkovic and Sibon, {Oda Cornelia Maria} and Balaji Srinivasan",

year = "2016",

month = jun,

day = "30",

language = "English",

type = "Patent",

note = "WO2016102680",

}

Kosec, G, Fujs, S, Petkovic, H, Sibon, OCM & Srinivasan, B jun.. 30 2016, Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides, Octrooi Nr. WO2016102680. <https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=WO&NR=2016102680A1&KC=A1&FT=D&ND=3&date=20160630&DB=&locale=en_EP>

TY - PAT

T1 - Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides

AU - Kosec, Gregor

AU - Fujs, Stefan

AU - Petkovic, Hrvoje

AU - Sibon, Oda Cornelia Maria

AU - Srinivasan, Balaji

PY - 2016/6/30

Y1 - 2016/6/30

N2 - The invention relates to the use of phosphopantetheine compounds alone and in combination with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Preferred medical uses relate to the treatment or prevention of dyslipidemia.

AB - The invention relates to the use of phosphopantetheine compounds alone and in combination with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Preferred medical uses relate to the treatment or prevention of dyslipidemia.

M3 - Patent

M1 - WO2016102680

ER -

Phosphopantetheine compounds alone or in combination with HMG-CoA reductase inhibitors for lowering serum cholesterol and serum triglicerides

Samenvatting

Toegang tot document

Handle.net

Vingerafdruk

Citeer dit